|
Heidrun Dame, MD, is VP of Pharmacovigilance and Medical Information with PROSAR. Dr. Dame's professional experience includes nine years in leadership positions in the pharmaceutical industry. Prior to joining PROSAR, she served as the Medical Director of Global Drug Safety and Pharmacovigilance at MGI PHARMA in Bloomington, MN. In this role she oversaw adverse event reporting for both clinical and post-marketing cases for a variety of prescription medicines including anticancer agents. Dr. Dame also worked as a Medical Manager for Boehringer Ingelheim and as a Medical Director for Laboratorios Best in Bogota, Colombia. She has experience in drug safety and pharmacovigilance, medical information, project management and clinical research. Dr. Dame received her Medical Degree and doctorate from Albert Ludwigs University in Freiburg, Germany. She practiced medicine for several years before joining the pharmaceutical industry. | 